326 related articles for article (PubMed ID: 15343229)
1. Increased fetal DNA in the maternal circulation in early pregnancy is associated with an increased risk of preeclampsia.
Cotter AM; Martin CM; O'leary JJ; Daly SF
Am J Obstet Gynecol; 2004 Aug; 191(2):515-20. PubMed ID: 15343229
[TBL] [Abstract][Full Text] [Related]
2. Increased fetal RhD gene in the maternal circulation in early pregnancy is associated with an increased risk of pre-eclampsia.
Cotter AM; Martin CM; O'Leary JJ; Daly SF
BJOG; 2005 May; 112(5):584-7. PubMed ID: 15842281
[TBL] [Abstract][Full Text] [Related]
3. [Study on the relation between concentration of circulating non-host fetal DNA in pregnant women and pre-eclampsia].
Tao H; Wang XM; Ji XH
Zhonghua Fu Chan Ke Za Zhi; 2005 Dec; 40(12):808-11. PubMed ID: 16412324
[TBL] [Abstract][Full Text] [Related]
4. Elevated plasma homocysteine in early pregnancy: a risk factor for the development of severe preeclampsia.
Cotter AM; Molloy AM; Scott JM; Daly SF
Am J Obstet Gynecol; 2001 Oct; 185(4):781-5. PubMed ID: 11641651
[TBL] [Abstract][Full Text] [Related]
5. Increased free fetal DNA levels in early pregnancy plasma of women who subsequently develop preeclampsia and intrauterine growth restriction.
Illanes S; Parra M; Serra R; Pino K; Figueroa-Diesel H; Romero C; Arraztoa JA; Michea L; Soothill PW
Prenat Diagn; 2009 Dec; 29(12):1118-22. PubMed ID: 19816882
[TBL] [Abstract][Full Text] [Related]
6. Fetal DNA quantitation in peripheral blood is not useful as a marker of disease severity in women with preeclampsia.
Byrne BM; Crowley A; Taulo F; Anthony J; O'Leary JJ; O'Herlihy C
Hypertens Pregnancy; 2003; 22(2):157-64. PubMed ID: 12909000
[TBL] [Abstract][Full Text] [Related]
7. Maternal plasma lipid concentrations in early pregnancy and risk of preeclampsia.
Enquobahrie DA; Williams MA; Butler CL; Frederick IO; Miller RS; Luthy DA
Am J Hypertens; 2004 Jul; 17(7):574-81. PubMed ID: 15233976
[TBL] [Abstract][Full Text] [Related]
8. Total cell-free DNA (beta-globin gene) distribution in maternal plasma at the second trimester: a new prospective for preeclampsia screening.
Farina A; Sekizawa A; Iwasaki M; Matsuoka R; Ichizuka K; Okai T
Prenat Diagn; 2004 Sep; 24(9):722-6. PubMed ID: 15386446
[TBL] [Abstract][Full Text] [Related]
9. Fetal DNA in maternal plasma as a screening variable for preeclampsia. A preliminary nonparametric analysis of detection rate in low-risk nonsymptomatic patients.
Farina A; Sekizawa A; Sugito Y; Iwasaki M; Jimbo M; Saito H; Okai T
Prenat Diagn; 2004 Feb; 24(2):83-6. PubMed ID: 14974111
[TBL] [Abstract][Full Text] [Related]
10. The analysis of the correlation between extracellular fetal DNA concentration in maternal circulation and severity of preeclampsia.
Engel K; Płonka T; Bilar M; Czajkowska E; Orzińska E; Brojer E; Ronin-Walknowska E
Ann Acad Med Stetin; 2007; 53(3):20-5. PubMed ID: 18595481
[TBL] [Abstract][Full Text] [Related]
11. Enrichment of fetal cells and free fetal DNA from maternal blood: An insight into the Basel experience.
Holzgreve W; Zhong XY; Burk MR; Hahn S
Early Pregnancy (Cherry Hill); 2001 Jan; 5(1):43-4. PubMed ID: 11753508
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the female fetal DNA concentration in the plasma of the pregnant women as preeclampsia indicator--preliminary report.
Karina E; Tomasz P; Bilar M; Agnieszka O; Ewa B; Elzbieta RW
Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):165-8. PubMed ID: 19632756
[TBL] [Abstract][Full Text] [Related]
13. Cell-free fetal DNA (SRY locus) concentration in maternal plasma is directly correlated to the time elapsed from the onset of preeclampsia to the collection of blood.
Farina A; Sekizawa A; Rizzo N; Concu M; Banzola I; Carinci P; Simonazzi G; Okai T
Prenat Diagn; 2004 Apr; 24(4):293-7. PubMed ID: 15065105
[TBL] [Abstract][Full Text] [Related]
14. Maternal cardiac output between 11 and 13 weeks of gestation in the prediction of preeclampsia and small for gestational age.
De Paco C; Kametas N; Rencoret G; Strobl I; Nicolaides KH
Obstet Gynecol; 2008 Feb; 111(2 Pt 1):292-300. PubMed ID: 18238965
[TBL] [Abstract][Full Text] [Related]
15. Lack of association of severe preeclampsia with maternal and fetal mutant alleles for tumor necrosis factor alpha and lymphotoxin alpha genes and plasma tumor necrosis factor alpha levels.
Livingston JC; Park V; Barton JR; Elfering S; Haddad B; Mabie WC; Quasney M; Sibai BM
Am J Obstet Gynecol; 2001 May; 184(6):1273-7. PubMed ID: 11349201
[TBL] [Abstract][Full Text] [Related]
16. Reduction of the disintegrin and metalloprotease ADAM12 in preeclampsia.
Laigaard J; Sørensen T; Placing S; Holck P; Fröhlich C; Wøjdemann KR; Sundberg K; Shalmi AC; Tabor A; Nørgaard-Pedersen B; Ottesen B; Christiansen M; Wewer UM
Obstet Gynecol; 2005 Jul; 106(1):144-9. PubMed ID: 15994630
[TBL] [Abstract][Full Text] [Related]
17. First trimester maternal serum placental protein 13 for the prediction of pre-eclampsia in women with a priori high risk.
Khalil A; Cowans NJ; Spencer K; Goichman S; Meiri H; Harrington K
Prenat Diagn; 2009 Aug; 29(8):781-9. PubMed ID: 19418482
[TBL] [Abstract][Full Text] [Related]
18. Quantification of cell free fetal DNA in maternal plasma in normal pregnancies and in pregnancies with placental dysfunction.
Alberry MS; Maddocks DG; Hadi MA; Metawi H; Hunt LP; Abdel-Fattah SA; Avent ND; Soothill PW
Am J Obstet Gynecol; 2009 Jan; 200(1):98.e1-6. PubMed ID: 19121662
[TBL] [Abstract][Full Text] [Related]
19. Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia.
Zhong XY; Laivuori H; Livingston JC; Ylikorkala O; Sibai BM; Holzgreve W; Hahn S
Am J Obstet Gynecol; 2001 Feb; 184(3):414-9. PubMed ID: 11228496
[TBL] [Abstract][Full Text] [Related]
20. First-trimester maternal plasma cell-free fetal DNA and preeclampsia.
Sifakis S; Zaravinos A; Maiz N; Spandidos DA; Nicolaides KH
Am J Obstet Gynecol; 2009 Nov; 201(5):472.e1-7. PubMed ID: 19631923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
